Global Lung Cancer Liquid Biopsy Market 2017-2021: Vendors' Focusing on Clinical Trials - Research and Markets

DUBLIN--()--The "Global Lung Cancer Liquid Biopsy Market 2017-2021" report has been added to Research and Markets' offering.

The report forecasts the global lung cancer liquid biopsy market to grow at a CAGR of 17.15% during the period 2017-2021.

The report, Global Lung Cancer Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the vendors' focus on clinical trials. The global lung cancer liquid biopsy market is in its growth stage, which offers a great platform for manufacturers to investigate on products through clinical trials. The increasing funding by big investors such as Amazon, GV, and Johnson and Johnson provides an opportunity for new entrants to penetrate the market with their novel products.

According to the report, one of the major drivers for this market is the rising incidence of lung cancer. Lung cancer is regarded as one of the highest causes of cancer deaths globally. The two types of lung cancers, which grow and spread differently, are SCLC and NSCLC. The major risk factors for the increased lung cancer are (tobacco) smoking and factors such as asbestosis, air pollution, passive smoking, and abnormalities observed in genes (changes in gene base pairing).

Key vendors

  • Biocept
  • Exosome Diagnostics
  • F. Hoffmann-La Roche
  • Qiagen

Other prominent vendors

  • AccuraGen
  • Agena Bioscience
  • BARD1
  • BGI
  • Biodesix
  • Epigenomics
  • Fluxion Biosciences
  • Freenome
  • Guardant Health
  • HeliTec
  • Others

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation By Product

Part 09: Market Segmentation By End-User

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Key Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/g3xdtg/global_lung

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics